Enteromorpha compressa extract induces anticancer activity through apoptosis and autophagy in oral cancer

Biswajita Pradhan1, Srimanta Patra2, Chhandashree Behera1

  • 1Algal Biotechnology and Molecular Systematic Laboratory, Post Graduate Department of Botany, Berhampur University, Bhanja Bihar, Berhampur, Odisha, 760007, India.

Molecular Biology Reports
|November 26, 2020
PubMed

Insights

Marine algae extracts show promise against oral cancer by inducing cell death pathways. Enteromorpha compressa extract demonstrated significant antioxidant and antiproliferative effects, suggesting potential as an alternative cancer therapy.

Area of Science:

  • Marine natural products
  • Cancer biology
  • Pharmacology

Background:

  • Marine algae are a rich source of bioactive compounds with potential anticancer properties.
  • The mechanisms underlying the anticancer effects of algal compounds, particularly against oral squamous cell carcinoma (OSCC), require further investigation.

Purpose of the Study:

  • To explore the phytochemical and antioxidant properties of Enteromorpha compressa extracts.
  • To investigate the ability of E. compressa extracts to induce autophagy and apoptosis in oral cancer cells.

Main Methods:

  • Phytochemical analysis using UV and FT-IR spectroscopy.
  • Assessment of antioxidant activity (DPPH, H2O2, superoxide, hydroxyl radical scavenging).
  • Evaluation of anticancer effects via clonogenic and scratch assays, apoptosis assays (DAPI, MMP), antioxidant enzyme activity (CAT, SOD, GPX, APX, GR), and autophagy markers (LC3 puncta, acridine orange, LysoTracker).

Main Results:

  • The methanolic extract of E. compressa exhibited strong free radical scavenging activity and antiproliferative effects.
  • The extract induced apoptosis in OSCC cells by downregulating protective antioxidant enzymes.
  • Autophagy was also induced in oral cancer cells, contributing to cell death.

Conclusions:

  • Enteromorpha compressa possesses bioactive compounds with significant therapeutic potential against OSCC.
  • These compounds modulate the antioxidant defense system, apoptosis, and autophagy, offering a promising avenue for developing novel anticancer drugs.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K